GRIN2B and Alzheimer disease: Therefore, selective inhibition on the internalisation of synaptic NR2B-NMDARs in AD (such as modifying key proteins in the NMDAR trafficking pathway [94]) could be a useful therapeutic approach that may prevent the loss of synapses and memory decline.